NR3C1 and cancer: In this study, we investigated the biological effects of novel GR ligands from the class of synephrine derivatives and demonstrated the anti-cancer effect of 1-[4-(benzyloxy)phenyl]-2-(hexylamino)ethanol (10S-E2) in vitro, in vivo, and ex vivo.